» Articles » PMID: 20236061

Virtual Screening in Drug Design and Development

Overview
Specialty Chemistry
Date 2010 Mar 19
PMID 20236061
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Virtual screening (VS) is presently a key component in the process of drug design and development. VS is normally regarded as the selection of likely drug candidates from large libraries of chemical structures by using computational methodologies. However, the generic definition of VS is significantly wider and may encompass many different methods. This review tries to present a comprehensive overview of the virtual screening process and of its importance in the present drug discovery and development paradigm. Following a focused contextualization on the subject, an introduction to the general types of virtual screening methodologies is presented. The main stages of a virtual screening campaign, including its strengths and limitations, are the subject of particular attention in this review. This analysis is complemented with a careful selection of VS success stories. Finally, a reflection on the future challenges of this promising methodology is drawn.

Citing Articles

High-Affinity Peptides for Target Protein Screened in Ultralarge Virtual Libraries.

Xue B, Li R, Cheng Z, Zhou X ACS Cent Sci. 2024; 10(11):2111-2118.

PMID: 39634215 PMC: 11613273. DOI: 10.1021/acscentsci.4c01385.


SARS-CoV-2 Infection may be Prevented with Cytochrome Inhibitors: Cobicistat and Ritonavir.

Celik I, Gulten E, Onay-Besikci A, Cinar G, Akdemir-Kalkan I, Kilcigil G Infect Dis Clin Microbiol. 2024; 4(3):185-191.

PMID: 38633393 PMC: 10986712. DOI: 10.36519/idcm.2022.139.


study for the identification of potential destabilizers between the spike protein of SARS-CoV-2 and human ACE-2.

Medina-Barandica J, Contreras-Puentes N, Taron-Dunoyer A, Duran-Lengua M, Alviz-Amador A Inform Med Unlocked. 2023; 40:101278.

PMID: 37305192 PMC: 10241490. DOI: 10.1016/j.imu.2023.101278.


Molecular docking analysis of lupeol with different cancer targets.

Gunasekaran M, Ravi R, Subramanian K Bioinformation. 2022; 18(3):134-140.

PMID: 36518133 PMC: 9722432. DOI: 10.6026/97320630018134.


Screening of Potent Phytochemical Inhibitors Against SARS-CoV-2 Main Protease: An Integrative Computational Approach.

Mahmud S, Hasan M, Biswas S, Paul G, Afrose S, Mita M Front Bioinform. 2022; 1:717141.

PMID: 36303755 PMC: 9581031. DOI: 10.3389/fbinf.2021.717141.